Borer Denton & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Sell |
57,984
-25
| -0% | -$4.64K | 3.74% | 8 |
|
|
2025
Q1 | $12.2M | Sell |
58,009
-1,225
| -2% | -$257K | 4.3% | 7 |
|
|
2024
Q4 | $10.5M | Buy |
59,234
+920
| +2% | +$163K | 3.66% | 7 |
|
|
2024
Q3 | $11.5M | Buy |
58,314
+1,405
| +2% | +$277K | 3.93% | 7 |
|
|
2024
Q2 | $9.76M | Sell |
56,909
-1,800
| -3% | -$309K | 3.54% | 8 |
|
|
2024
Q1 | $10.7M | Buy |
58,709
+694
| +1% | +$126K | 3.78% | 8 |
|
|
2023
Q4 | $8.99M | Hold |
58,015
| – | – | 3.44% | 12 |
|
|
2023
Q3 | $8.65M | Hold |
58,015
| – | – | 3.57% | 12 |
|
|
2023
Q2 | $7.82M | Hold |
58,015
| – | – | 3.08% | 14 |
|
|
2023
Q1 | $9.25M | Buy |
58,015
+503
| +0.9% | +$80.2K | 3.84% | 11 |
|
|
2022
Q4 | $9.29M | Buy |
57,512
+362
| +0.6% | +$58.5K | 4.12% | 7 |
|
|
2022
Q3 | $7.67M | Sell |
57,150
-102
| -0.2% | -$13.7K | 3.82% | 9 |
|
|
2022
Q2 | $8.77M | Sell |
57,252
-100
| -0.2% | -$15.3K | 4.23% | 8 |
|
|
2022
Q1 | $9.3M | Buy |
+57,352
| New | +$9.3M | 3.9% | 8 |
|